64 Results for "

SDZ

" in MedChemExpress (MCE) Product Catalog:
Products (64)

64 Results for "SDZ" in MCE Product Catalog:

125
125 Publications Verification
Cat. No.: HY-10218
CAS No.: 159351-69-6
Purity:  99.85%
Synonyms: RAD001; SDZ-RAD
Everolimus (RAD001) is a Rapamycin (HY-10219) derivative and a potent, selective, orally active, blood-brain barrier-permeable mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-P0025
CAS No.: 143205-42-9
Synonyms: (Melle-4)cyclosporin; SDZ NIM811
NIM811 ((Melle-4)cyclosporin; SDZ NIM811) is an orally bioavailable mitochondrial permeability transition and cyclophilin dual inhibitor, which exhibits potent in vitro activity against hepatitis C virus (HCV) .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-13723
CAS No.: 137071-32-0
Purity:  99.53%
Synonyms: SDZ-ASM 981
Target:  

Phosphatase

Research Areas:  

Inflammation/Immunology

Pimecrolimus (SDZ-ASM 981) is a potent, nonsteroid and orally active calcineurin inhibitor with a Ki of 117 nM. Pimecrolimus shows anti-inflammatory activity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-B0020
CAS No.: 105826-92-4
Synonyms: SDZ-ICS-930
Tropisetron Hydrochloride (SDZ-ICS-930) is an effective neuroprotective agent that acts as a 5-HT3 receptor antagonist, a calmodulin inhibitor, and an α7-nAChRreceptor agonist, with an IC50 of 70.1 nM for the 5-HT3 receptor. Tropisetron Hydrochloride has anti-inflammatory properties and immune-regulating functions, effectively alleviating symptoms associated with chemotherapy and post-surgery. Tropisetron Hydrochloride reduces Ab (HY-P4867)-induced hippocampal neuroinflammation .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-B0072
CAS No.: 89565-68-4
Synonyms: SDZ-ICS-930 free base
Tropisetron is an orally active 5-HT3R antagonist (Ki = 5.3 nM) as well as being a potent and selective α7 nicotinic partial agonist (EC50 = 1.3 μM). Tropisetron prevents phosphorylation and activation of the p38 MAPK. Tropisetron inhibits both IL-2 gene transcription and IL-2 synthesis in stimulated T cells. Tropisetron inhibits the binding to DNA and the transcriptional activity of NFAT and AP-1. Tropisetron is anti-inflammatory and antiemetic. Tropisetron has antitumor and neuroprotective effects. Tropisetron can be studied in research for diseases including hemorrhagic cystitis, chronic joint inflammation, lung cancer and chronic cerebral hypoperfusion .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-14153A
CAS No.: 189188-57-6
Purity:  99.90%
Synonyms: SDZ-HTF-919; HTF-919
Tegaserod maleate (SDZ-HTF-919) is an orally active serotonin receptor 4 (HTR4; 5-HT4R) agonist and a 5-HT2B receptor antagonist. Tegaserod maleate has pKis of 7.5, 8.4 and 7.0 for human recombinant 5-HT2A, 5-HT2B and 5-HT2C receptors, respectively. Tegaserod maleate causes tumor cell apoptosis, blunts PI3K/Akt/mTOR signaling and decreases S6 phosphorylation. Tegaserod maleate has anti-tumor activity and has the potential for irritable bowel syndrome (IBS) research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-106033
CAS No.: 204318-14-9
Purity:  98.15%
Synonyms: DOTATOC; SDZ-SMT 487; SMT 487
Research Areas:  

Cancer

Edotreotide is a ligand that selectively targets SSTR2 and can competitively bind to the receptor. Edotreotide mediates the targeted delivery, while modificated with radionuclides (such as 90Y, 177Lu, and 68Ga) to SSTR-positive tumors and induces tumor cell apoptosis by releasing β rays. Edotreotide has strong tumor targeting and precise killing activity. Edotreotide is used in the synthesis of radionuclide-drug conjugates (RDCs) and is widely used in the field of neuroendocrine tumors (such as metastatic carcinoids, lung and thymus NETs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-17368
CAS No.: 123441-03-2
Synonyms: ENA 713 free base; SDZ-ENA 713 free base
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease

Rivastigmine (ENA 713 free base) is an orally active and potent cholinesterase (ChE) inhibitor and inhibits butyrylcholinesterase (BChE) and acetylcholinesteras (AChE) with IC50s of 0.037 μM , 4.15 μM, respectively. Rivastigmine can pass the blood brain barrier (BBB). Rivastigmine is a parasympathomimetic or cholinergic agent used for the research of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-11017
CAS No.: 129101-54-8
Purity:  99.03%
Synonyms: ENA 713; SDZ-ENA 713
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease

Rivastigmine tartrate (ENA 713; SDZ-ENA 713) is an orally active and potent cholinesterase (ChE) inhibitor and inhibits butyrylcholinesterase (BChE) and acetylcholinesteras (AChE) with IC50s of 0.037 μM, 4.15 μM, respectively. Rivastigmine tartrate can pass the blood brain barrier (BBB). Rivastigmine tartrate is a parasympathomimetic or cholinergic agent used for the research of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1497
CAS No.: 22199-08-2
Synonyms: AgSD
Research Areas:  

Infection

Silver sulfadiazine (AgSD), a sulfonamide antibiotic, effects a dual inhibitory action on bacterial growth by its sulfa moiety (SD-SDZ) that prevents bacterial folate absorption and subsequent DNA synthesis. The silver that is released from Silver sulfadiazine binds and disrupts the DNA structure, precluding bacterial DNA replication .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B2221B1
CAS No.: 9004-62-0
Research Areas:  

Others

Hydroxyethyl cellulose, Viscosity(2%):150mPa.s is a class of nonionic cellulose ether gel-forming polymers with pH-independent drug release properties. When used as a tablet coating, Hydroxyethyl cellulose, Viscosity(2%):150mPa.s regulates the water permeation rate, thereby altering the drug release lag time; the higher the viscosity, the longer the drug release lag time. When used as a hydrogel thickener, it increases the dynamic viscosity of the system. Hydroxyethyl cellulose, Viscosity(2%):150mPa.s can be used in organic synthesis-related research, such as pharmaceutical excipients, hydrogel thickeners, etc.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19666
CAS No.: 97730-95-5
Synonyms: SDZ 201106
Target:  

Sodium Channel

Research Areas:  

Cardiovascular Disease

DPI 201-106 (SDZ 201106) is a cardiotonic agent with a synergistic sarcolemmal and intracellular mechanism of action. DPI 201-106 shows cardioselective modulation of voltage-gated sodium channels (VGSCs) resulting in a positive inotropic effect .
loading...
    loading...
Cat. No.: HY-10218S
CAS No.: 1338452-54-2
Purity:  98.74%
Synonyms: RAD001-d4; SDZ-RAD-d4
Everolimus-d4 is the deuterium labeled Everolimus. Everolimus (RAD001) is a Rapamycin derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities .
loading...
    loading...
Cat. No.: HY-10218R
CAS No.: 159351-69-6
Synonyms: RAD001 (Standard); SDZ-RAD (Standard)
Research Areas:  

Cancer

Everolimus (Standard) is the analytical standard of Everolimus. This product is intended for research and analytical applications. Everolimus (RAD001) is a Rapamycin (HY-10219) derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities .
loading...
    loading...
Cat. No.: HY-13059
CAS No.: 174575-17-8
Purity:  99.20%
Target:  

iGluR

Research Areas:  

Neurological Disease

SDZ 220-581 is an orally active, potent, competitive NMDA receptor antagonist with pKi value of 7.7 .
loading...
    loading...
Cat. No.: HY-108938
CAS No.: 174262-13-6
Purity:  98.00%
Research Areas:  

Infection

SDZ285428 is a CYP51 inhibitor. SDZ285428 inhibits Trypanosoma cruzi (TC) CYP51 with I/E2 <1 (5 min) and I/E2=9 (1 h). SDZ285428 inhibits Trypanosoma brucei (TB) CYP51 with I/E2 <1 (5 min) and I/E2=35 (1 h) .
loading...
    loading...
Cat. No.: HY-P99541
CAS No.: 138660-97-6
Synonyms: anti-hepatitis B; OST 577; SDZ-OST 577

Target:  

HBV

Research Areas:  

Infection

Tuvirumab (OST 577; SDZ-OST 577) is a human IgG1 subclass monoclonal antibody directed against HBV surface antigen (HBsAg). Tuvirumab binds specifically and with high affinity (K=3.6 nM) to HBsAg. Tuvirumab has the potential for chronic hepatitis B research .
loading...
    loading...
Cat. No.: HY-100164
CAS No.: 114606-56-3
Purity:  99.77%
Synonyms: MKS 492
Research Areas:  

Inflammation/Immunology

SDZ-MKS 492 (MKS 492) is a selective inhibitor of cyclic GMP-inhibited phosphodiesterase (type III PDE). SDZ-MKS 492 inhibits antigen- or platelet activating factor (PAF)-induced bronchoconstriction and allergic reactions in guinea pigs and rats .
loading...
    loading...
Cat. No.: HY-17368R
CAS No.: 123441-03-2
Synonyms: ENA 713 free base(Standard); SDZ-ENA 713 free base(Standard)
Rivastigmine (Standard) is the analytical standard of Rivastigmine. This product is intended for research and analytical applications. Rivastigmine (ENA 713 free base) is an orally active and potent cholinesterase (ChE) inhibitor and inhibits butyrylcholinesterase (BChE) and acetylcholinesteras (AChE) with IC50s of 0.037 μM , 4.15 μM, respectively. Rivastigmine can pass the blood brain barrier (BBB). Rivastigmine is a parasympathomimetic or cholinergic agent used for the research of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease .
loading...
    loading...
Cat. No.: HY-B2221B2
CAS No.: 9004-62-0
Research Areas:  

Others

Hydroxyethyl cellulose, Viscosity (2%):40000mPa.s is a class of nonionic cellulose ether gel-forming polymers with pH-independent drug release properties. When used as a tablet coating, Hydroxyethyl cellulose, Viscosity (2%):40000mPa.s regulates the water permeation rate, thereby altering the drug release lag time; the higher the viscosity, the longer the drug release lag time. When used as a hydrogel thickener, it increases the dynamic viscosity of the system. Hydroxyethyl cellulose, Viscosity (2%):40000mPa.s can be used in organic synthesis-related research, such as pharmaceutical excipients, hydrogel thickeners, etc.
loading...
    loading...